View Audits List (FRENCH) 
Recommencer
Prestation Nom de la Société Ville Date
Principe actif (API) Quingdao Taitong Pharmaceutical Co.Ltd. Shandong

2023-03-03
Principe actif (API) Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co. Ltd. Yichang

TBD
Principe actif (API) Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co. Ltd. Yichang

2023-03-20
Principe actif (API) Second Pharma Co. Ltd. Shangyu

2024-07-30
Principe actif (API) SEL Biochem Xinjiang Co. Ltd. Shihezi

2023-04-20
Principe actif (API) Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. Hanzhong

TBD
Autres Shaanxi Healthful Bioengineering Co. Ltd. Xianyang

2025-02-11
Principe actif (API) Shandong Anhong Pharmaceutical Co Ltd. Dezhou

2024-04-16
Autres Shandong Anxin Pharmaceutical Company Limited Jinan

2023-07-26
Principe actif (API) Shandong Anxin Pharmaceutical Company Limited Jinan

2024-10-21
Autres Shandong Chenghui Shuangda Pharmaceutical Dezhou

TBD
Principe actif (API) Shandong Guobang Pharmaceutical Company Limited Weifang

2023-12-27
Principe actif (API) Shandong Lukang Pharmaceutical Co. Ltd. Zoucheng

2024-09-24
Principe actif (API) Shandong Lukang Shelile Pharmaceutical Co. Ltd. Zoucheng

2025-07-15
Autres Shandong New Time Pharmaceutical Co. Ltd. Linyi

2024-03-15
Principe actif (API) Shandong New Time Pharmaceutical Co. Ltd. Linyi

2023-05-09
Autres Shandong Pharmaceutical Glass Co. Ltd. Zibo

2024-12-03
Principe actif (API) Shandong Qilu King-phar Pharmaceutical Co. Ltd. Jinan

2024-03-24
Principe actif (API) Shandong Qilu King-phar Pharmaceutical Co. Ltd. Jinan

2024-03-13
Principe actif (API) Shandong Shengli Bioengineering Co. Ltd. Jining

2025-06-17
Principe actif (API) Shandong Xinhua East Park Site Shandong Province

2023-12-05
Principe actif (API) Shandong Xinhua Pharmaceutical Co. Ltd. Shandong

2025-09-17
Principe actif (API) Shandong Xinhua Pharmaceutical Co. Ltd. Zibo

2023-12-05
Principe actif (API) Shandong Xinhua Pharmaceutical Co. Ltd. Zibo

TBD
Principe actif (API) Shanghai Desano Chemical Pharmaceutical Co. Ltd. Shanghai

TBD